VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
STVNStevanato Group S.p.A.
$17.84$4.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksSTVNFinancials

Stevanato Group S.p.A. (STVN) Financials

7Y historyFree accessUpdated daily

Revenue growth remains cyclically uneven, with quarterly performance ranging from a 0.8% contraction in 2024Q1 to a 9.8% expansion in 2023Q4, while operating margins have struggled to stabilize above 14.2% as of 2026Q1.

STVN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Sales/Revenue1.2B1.14B1.1B1.09B983.68M843.92M662.04M536.54M
Revenue Growth %6.7%3.21%1.72%10.34%16.56%27.47%23.39%-
Cost of Goods Sold851.87M809.15M801.72M745.46M663.88M578.51M467.86M398.52M
COGS % of Revenue-71.01%72.62%68.68%67.49%68.55%70.67%74.28%
Gross Profit348.16M330.33M302.32M339.89M319.8M265.4M194.18M138.02M
Gross Margin %29.01%28.99%27.38%31.32%32.51%31.45%29.33%25.72%
Gross Profit Growth %-9.26%-11.05%6.28%20.5%36.68%40.69%-
Operating Expenses149.36M147.25M141.18M139.17M127.37M103.18M91.07M75.8M
OpEx % of Revenue-12.92%12.79%12.82%12.95%12.23%13.76%14.13%
Selling, General & Admin127.07M122.85M118.6M113.92M111.83M82.95M78.91M76.71M
SG&A % of Revenue-10.78%10.74%10.5%11.37%9.83%11.92%14.3%
Research & Development25.28M24.4M31.67M35.67M34.39M29.62M17.39M7.83M
R&D % of Revenue-2.14%2.87%3.29%3.5%3.51%2.63%1.46%
Other Operating Expenses-1.27M0-9.09M-10.42M-18.85M-9.39M-5.23M-8.74M
Operating Income198.8M183.08M161.14M200.72M192.43M162.22M103.11M62.22M
Operating Margin %16.57%16.07%14.6%18.49%19.56%19.22%15.57%11.6%
Operating Income Growth %-13.61%-19.72%4.31%18.62%57.33%65.72%-
EBITDA291.17M268.18M241.79M279.2M257.25M218.61M157.21M108.44M
EBITDA Margin %24.26%23.54%21.9%25.72%26.15%25.9%23.75%20.21%
EBITDA Growth %-0.49%10.91%-13.4%8.53%17.68%39.05%44.98%-
D&A (Non-Cash Add-back)92.37M85.1M80.65M78.48M64.82M56.38M54.1M46.22M
EBIT198.09M183.08M167.15M193.87M191.58M170.54M102.27M60.32M
Net Interest Income-8.19M-9.32M-5.14M-3.52M-3.29M-4.32M-6.37M-5.1M
Interest Income1.01M12.49M1.72M792K648K548K424.07K195.87K
Interest Expense9.2M21.8M6.86M4.32M3.94M4.87M6.79M5.3M
Other Income/Expense-6.14M-1.44M-854K-11.17M-4.79M3.45M-6.83M-7.51M
Pretax Income192.66M181.64M160.29M189.55M187.64M165.67M96.28M54.71M
Pretax Margin %16.05%15.94%14.52%17.46%19.08%19.63%14.54%10.2%
Income Tax51.71M47.35M42.52M43.86M44.63M31.4M17.68M16.01M
Effective Tax Rate %26.84%26.07%26.53%23.14%23.78%18.96%18.37%29.26%
Net Income140.95M134.28M117.78M145.63M142.85M134.32M78.51M39.2M
Net Margin %11.75%11.78%10.67%13.42%14.52%15.92%11.86%7.31%
Net Income Growth %12.33%14.01%-19.13%1.95%6.35%71.08%100.28%-
Net Income (Continuing)140.94M134.28M117.77M145.69M143.02M134.27M78.6M38.71M
Discontinued Operations00000000
Minority Interest36K37.98K46K115K-220K-415K-355K-50K
EPS (Diluted)0.520.490.430.550.530.530.280.15
EPS Growth %9.54%13.95%-21.82%3.77%0%89.29%86.67%-
EPS (Basic)-0.490.430.550.530.530.280.15
Diluted Shares Outstanding273.02M273M272.88M264.98M264.7M264.7M264.7M264.7M
Basic Shares Outstanding273M273M272.87M264.95M264.7M264.7M264.7M264.7M
Dividend Payout Ratio-10.54%12.27%9.82%9.45%8.34%11.34%15.74%

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Energy cost volatility exposure

Revenue Growth Remains Cyclically Uneven

According to the provided income statement data, STVN's quarterly revenue growth has fluctuated significantly, ranging from a contraction of 0.8% in 2024Q1 to a peak growth of 9.8% in 2023Q4, reflecting the inherent lumpiness of project-based engineering milestones alongside more stable biopharmaceutical containment demand.

The revenue trajectory appears heavily influenced by the timing of large-scale engineering projects, which can mask the underlying performance of the recurring BDS segment. Investors should monitor whether the recent 6.6% growth in 2026Q1 represents a sustainable baseline or if the company remains susceptible to the lumpy recognition patterns typical of its industrial automation business.

Gross Margin Sensitivity to Mix

As reported in financial statements, STVN's gross margin has oscillated between 26.0% and 31.8% over the last ten quarters, suggesting that the company's profitability is highly sensitive to the product mix between high-value ready-to-use solutions and lower-margin bulk glass or engineering-heavy project work.

The compression observed in 2026Q1 to 27.5% from the 30.9% peak in 2025Q4 warrants further investigation into whether this reflects a shift in product mix or increased input costs. The inability to consistently maintain margins above 30% suggests that the company's pricing power may be constrained by the competitive landscape of primary packaging.

Operating Leverage Remains Under Pressure

Based on the company's reported figures, operating margins have demonstrated significant volatility, peaking at 20.2% in 2024Q4 before declining to 14.2% in 2026Q1, indicating that the firm has yet to achieve the consistent operating leverage required to scale profitability efficiently alongside its revenue base.

The lack of clear operating margin expansion despite revenue growth suggests that fixed costs, particularly those associated with new facility ramps like the Fishers plant, are currently outpacing incremental gross profit gains. This trend implies that management's focus on global capacity expansion is creating a temporary drag on the bottom line that may persist until utilization rates reach critical mass.

Expense Discipline Amidst Capital Intensity

Data from recent filings indicates that STVN has maintained relatively disciplined SG&A spending, which has generally hovered around $30 million per quarter, even as the company navigates the complex operational requirements of its global manufacturing footprint and ongoing investments in proprietary drug delivery technologies.

While SG&A remains controlled, the high capital intensity of the business model necessitates constant monitoring of R&D and maintenance expenditures. The company's ability to keep these costs stable while scaling its international operations appears to be a key factor in preventing further margin erosion during periods of revenue volatility.

STVN — Frequently Asked Questions

Quick answers to the most common questions about buying STVN stock.

What was Stevanato Group S.p.A.'s (STVN) revenue in 2025?

For fiscal year 2025, Stevanato Group S.p.A. (STVN) reported total revenue of $1.14B. This represents a 112.4% increase compared to $536.5M in 2019.

Is Stevanato Group S.p.A. (STVN) profitable?

Stevanato Group S.p.A. (STVN) is profitable, generating $134.3M in net income for the fiscal year ending 2025 with a net profit margin of 11.8%.

What is Stevanato Group S.p.A.'s operating profit margin?

Stevanato Group S.p.A. (STVN) reported an operating income of $183.1M, resulting in an operating profit margin of 16.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Stevanato Group S.p.A.'s gross profit and gross margin?

Stevanato Group S.p.A. (STVN) generated $330.3M in gross profit for the year, representing a gross profit margin of 29.0%. This demonstrates the company's core pricing power and production efficiency.